The Rockefeller University | Teaching the immune system to control HIV
Results from a phase 2 clinical trial show that broadly neutralizing antibodies can suppress HIV long-term, keeping virus levels undetectable for months and even years.
Results from a phase 2 clinical trial show that broadly neutralizing antibodies can suppress HIV long-term, keeping virus levels undetectable for months and even years.